Editorial: tegoprazan-the newest advance in the management of acid-related diseases

Aliment Pharmacol Ther. 2020 Sep;52(6):1074-1075. doi: 10.1111/apt.15963.

Authors

Elizabeth A Marcus^{1

2}, Joseph R Pisegna^{2

3

4}

Affiliations

¹ Department of Paediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
² VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
³ Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
⁴ Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

PMID: 33119154
DOI: 10.1111/apt.15963

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Comment

MeSH terms

Benzene Derivatives
Humans
Imidazoles
Lansoprazole
Potassium
Stomach Ulcer*

Substances

Benzene Derivatives
Imidazoles
Lansoprazole
Potassium
tegoprazan

Grants and funding